Gainers
- Chemomab Therapeutics CMMB shares moved upwards by 65.6% to $1.01 during Wednesday's pre-market session. The market value of their outstanding shares is at $11.3 million. As per the news, the Q3 earnings report came out 4 days ago.
- Heart Test Laboratories HSCS stock moved upwards by 41.85% to $0.26. The company's market cap stands at $2.7 million.
- Kinnate Biopharma KNTE shares increased by 35.66% to $2.13. The market value of their outstanding shares is at $100.3 million. As per the press release, Q3 earnings came out 4 days ago.
- Heron Therapeutics HRTX stock moved upwards by 25.92% to $0.68. The market value of their outstanding shares is at $95.7 million. As per the press release, Q3 earnings came out yesterday.
- Solid Biosciences SLDB stock rose 25.35% to $2.67. The company's market cap stands at $53.8 million.
- Cormedix CRMD shares rose 21.72% to $3.81. The company's market cap stands at $208.8 million. The company's, Q3 earnings came out yesterday.
Losers
- Graphite Bio GRPH stock fell 14.6% to $1.99 during Wednesday's pre-market session. The company's market cap stands at $115.3 million.
- SILO Pharma SILO shares decreased by 11.54% to $1.15. The company's market cap stands at $3.5 million.
- GT Biopharma GTBP stock decreased by 11.12% to $0.2. The company's market cap stands at $8.2 million.
- Tivic Health Systems TIVC stock declined by 10.1% to $1.96. The market value of their outstanding shares is at $2.8 million. As per the news, the Q3 earnings report came out yesterday.
- Aditxt ADTX shares fell 9.94% to $4.35. The market value of their outstanding shares is at $1.9 million.
- Varex Imaging VREX stock decreased by 9.64% to $17.54. The market value of their outstanding shares is at $708.6 million. As per the news, the Q4 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in